RU93039306A - ANTIPROTEINASE MEDICINE - Google Patents

ANTIPROTEINASE MEDICINE

Info

Publication number
RU93039306A
RU93039306A RU93039306/14A RU93039306A RU93039306A RU 93039306 A RU93039306 A RU 93039306A RU 93039306/14 A RU93039306/14 A RU 93039306/14A RU 93039306 A RU93039306 A RU 93039306A RU 93039306 A RU93039306 A RU 93039306A
Authority
RU
Russia
Prior art keywords
antiproteinase
proteinases
medicine
activity
serine
Prior art date
Application number
RU93039306/14A
Other languages
Russian (ru)
Other versions
RU2053789C1 (en
Inventor
Т.А. Валуева
В.Н. Гапанович
П.Т. Петров
Л.И. Валуев
Н.А. Платэ
В.М. Царенков
Н.Л. Матвеев
Е.Д. Расюк
Original Assignee
Производственное объединение "Белмедпрепараты"
Filing date
Publication date
Application filed by Производственное объединение "Белмедпрепараты" filed Critical Производственное объединение "Белмедпрепараты"
Priority to RU93039306A priority Critical patent/RU2053789C1/en
Priority claimed from RU93039306A external-priority patent/RU2053789C1/en
Application granted granted Critical
Publication of RU2053789C1 publication Critical patent/RU2053789C1/en
Publication of RU93039306A publication Critical patent/RU93039306A/en

Links

Claims (1)

Изобретение относится к области медицины, а именно к лечебным антипротеиназным препаратам, и может быть использовано для коррекции состояний, связанных с повышением протеолитической активности в тканях, крови и других биологических жидкостях. Изобретение позволяет создать антипротеиназный препарат на основе белкового ингибитора протеиназ, обладающий поливалентной антипротеиназной активностью по отношению к сериновым панкреатическим и лейкоцитарным протеиназам, способностью оказывать пролонгированное лечебное действие и не подавлять активность сериновых протеиназ калликреин-кининовой и свертывающей систем крови. Сущность изобретения состоит в том, что в качестве основного компонента антипротеиназного препарата используют овомукоид из белка утиных яиц.The invention relates to medicine, namely to therapeutic antiproteinase drugs, and can be used to correct conditions associated with increased proteolytic activity in tissues, blood and other biological fluids. EFFECT: invention makes it possible to create an antiproteinase preparation based on a protein inhibitor of proteinases, having polyvalent antiproteinase activity against serine pancreatic and leukocyte proteinases, the ability to have a prolonged therapeutic effect and not suppress the activity of serine proteinases of kallikrein-kinin and blood coagulation systems. The essence of the invention lies in the fact that as the main component of the antiproteinase drug use an ovomukoid from the protein of duck eggs.
RU93039306A 1993-08-02 1993-08-02 Antiproteinase preparation RU2053789C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU93039306A RU2053789C1 (en) 1993-08-02 1993-08-02 Antiproteinase preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU93039306A RU2053789C1 (en) 1993-08-02 1993-08-02 Antiproteinase preparation

Publications (2)

Publication Number Publication Date
RU2053789C1 RU2053789C1 (en) 1996-02-10
RU93039306A true RU93039306A (en) 1996-10-10

Family

ID=20146011

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93039306A RU2053789C1 (en) 1993-08-02 1993-08-02 Antiproteinase preparation

Country Status (1)

Country Link
RU (1) RU2053789C1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2639414C1 (en) * 2017-02-06 2017-12-21 Федеральное государственное бюджетное учреждение науки Ордена Трудового Красного Знамени Институт нефтехимического синтеза им. А.В. Топчиева Российской академии наук (ИНХС РАН) Antiproteinase preparation
WO2023131595A1 (en) * 2022-01-04 2023-07-13 Solution Shop Ag Ovomucoid for use in a method of managing blood coagulation

Similar Documents

Publication Publication Date Title
ES2123134T3 (en) BIOLOGICALLY ACTIVE PEPTIDES OF FUNCTIONAL DOMAINS OF PERMEABILITY-INCREASING BACTERICIDE PROTEIN AND USES THEREOF.
EA199900773A1 (en) ANTI-MICROBIAL PREVENTION AND TREATMENT OF DISEASES CAUSED BY THE VIRUS OF HUMAN IMMUNODEFICIENCY AND OTHER INFECTIONS
DE69829721D1 (en) Use of activated protein C for the treatment of excessive blood clotting in sepsis
CA2181150A1 (en) Biologically Active Peptides from Functional Domains of Bactericidal/Permeability-Increasing Protein and Uses Thereof
ATE431364T1 (en) INHIBITORS OF HUMAN NEUTROPHIL ELASTASIS
ATE132757T1 (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF PROLONGED CLOTTING TIME
ES2183805T3 (en) PROCEDURE FOR PREPARATION OF A THROMBOLITIC MEDICINAL PRODUCT.
GOLDEN Livedo reticularis in systemic lupus erythematosus
RU93039306A (en) ANTIPROTEINASE MEDICINE
DK1341813T3 (en) Use of L-carnitine as a stabilizer of proteins
ATE249837T1 (en) CASPASE 8 INHIBITORS FOR IMMUNOSUPRESSION
ATE62789T1 (en) AGENT TO COMBAT PHYTOPATHOGENIC MICROBES.
RU93030389A (en) MEANS RESTORING THE FUNCTION OF THE MESH EYE
Kumar et al. Snake bite: The neglected tropical disease (NTD)
Johan-Arief et al. Venomous Terrestrial Snakes in the Tropics of Malaysia
DE69430807D1 (en) METHOD FOR TREATING LIVER DISEASES AND SIMILAR INDICATIONS WITH VASODILATING ACTIVE SUBSTANCES
Kernahan Recent and current trends in burn research and treatment.
al-Shukri et al. The effect of prostatilen on the hemostatic indices in chronic prostatitis (a clinical and experimental study)
RU93008090A (en) METHOD OF TREATMENT OF DEEP FROZEN BRUSHES
RU94023794A (en) Immunomodulators showing antimicrobial properties (variants)
RU97120340A (en) ACTIVE BEGINNING FOR MEDICAL MEANS AND MEDICAL MEANS
RU93052444A (en) MEDICINE BAN
RU96111078A (en) METHOD FOR SELECTING MEDICINAL TREATMENT OF RETINAL VEIN THROMBOSIS
RU93021719A (en) METHOD OF TREATMENT OF THE RETINA
RU93057198A (en) PATIENT TREATMENT METHOD